Latest filing published 29 Aug 2023 for AELIS FARMA, €2,750. Read the official filing
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pier Vincenzo Piazza is a declared insider of Aelis Farma, with filings sourced from AMF. In total, 6 filings cover trades dated from 2 March 2023 to 24 August 2023.
In open-market terms, that means 5 purchases worth €7,080 on one side and 1 sale worth €150k on the other. On balance, insiders were net sellers of €143k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €698. No cluster: in 5 purchases, no other insider of the company bought within 30 days. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -2.5%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 29 August 2023 with an open-market purchase (€2,750) in Aelis Farma. Filings reach the AMF feed a median of 5 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations